The new guidelines from the American Academy of Dermatology and the National Psoriasis Foundation are the first of its kind to focus on pediatric psoriasis, according to Joel M. Gelfand, MD, MSCE, professor of dermatology and epidemiology at University of Pennsylvania Perelman School of Medicine.

The guidelines, published in Journal of the American Academy of Dermatology, cover the relevant screening tools used to measure psoriasis severity, screening or therapeutic interventions, along with efficacy and adverse events from monotherapy or combination treatments.

Read the full article at